Baxter International Inc(BAX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | - | EPS (ttm) | -1.93 | Insider Own | 0.64% | Shs Outstand | 517.0M | Perf Week | 1.2% |
| Market Cap | 13.07B | Forward P/E | 12.37 | EPS next Y | -0.33% | Insider Trans | - | Shs Float | 513.7M | Perf Month | 8.22% |
| Enterprise Value | 19.75B | PEG | - | EPS next Q | 0.52 | Inst Own | 109.72% | Short Float | 4.74% | Perf Quarter | 3.78% |
| Income | -0.99B | P/S | 1.14 | EPS this Y | -7.21% | Inst Trans | 4.34% | Short Ratio | 3.67 | Perf Half Y | 36.78% |
| Sales | 11.47B | P/B | 2.11 | EPS next 5Y | -0.6% | ROA | -4.74% | Short Interest | 24.37M | Perf YTD | 32.34% |
| Book/sh | 12 | P/C | 6.08 | EPS past 3/5Y | 24.78% - | ROE | -14.31% | 52W High | -15.7% ($30.00) | Perf Year | 9.86% |
| Cash/sh | 4.16 | P/FCF | 16.04 | Sales past 3/5Y | -8.14% -0.75% | ROIC | -6.96% | 52W Low | 60.78% ($15.73) | Perf 3Y | -22.06% |
| Dividend Est. | $0.04 (0.16%) | EV/EBITDA | 12.36 | EPS Y/Y TTM | -632.85% | Gross Margin | 31.85% | Volatility(W/M) | 3.52% 2.91% | Perf 5Y | -69.08% |
| Dividend TTM | 0.04 | EV/Sales | 1.72 | Sales Y/Y TTM | 5.36% | Oper. Margin | 5.62% | ATR (14) | 0.74 | Perf 10Y | -46.69% |
| Dividend Ex-Date | 2026/8/28 | Quick Ratio | 1.32 | EPS Q/Q | 11.61% | Profit Margin | -8.63% | RSI (14) | 56.7 | Recom | 2.88 |
| Dividend Gr. 3/5Y | -23.25% -11.35% | Current Ratio | 1.95 | Sales Q/Q | 5.34% | SMA20 | 2.94% ($24.57) | Beta | 0.66 | Target Price | $26.82 |
| Payout | - | Debt/Eq | 1.43 | Earnings | 2026/10/29 | SMA50 | 2.21% ($24.74) | Rel Volume | 0.61 | Prev Close | $25.3 |
| Employees | 37500 | LT Debt/Eq | 1.29 | EPS/Sales Surpr. | 52.8% 5.88% | SMA200 | 18.97% ($21.26) | Avg Volume(3M) | 6.64M | Price | $25.29 |
| IPO | 1961/5/16 | Option/Short | Yes/Yes | Trades | 23743 | Volume | 4,043,646 | Change | -0.04% |
A U.S. medical device and pharmaceutical company, this global medical products firm manufactures IV (intravenous) solutions, infusion pumps, and hospital-grade medical products, supplying them to hospitals and healthcare facilities. Demand for essential hospital products provides a stable foundation for the business.
Over the past 1 year, roughly in the middle
16% below its 1-year high.
Traded less than usual. That is 61% of its average volume.
Next earnings report: October 29
2 days to go.
BAX keeps an operating profit but posts a net loss
Of every $100 in sales, $5.62 is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -7.2% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $114. Peers typically go for $270. Compared with its own 2-year average, it is 364% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -69.1%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.16% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 109.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #8 of 51 in the industry
Based on market cap of $13B.
SOLV#7 Solventum Corp $15B PER 10.5 BAX#8 Baxter International Inc $13B PER - 
AVTR#9 Avantor Inc $12B PER - 
COO#10 Cooper Companies Inc $12B PER 20.9 
RGEN#11 Repligen Corp $11B PER 245.6 
FAQ
What kind of company is BAX?
BAX belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of BAX?
The market cap of BAX is approximately $13.1B, ranking 767 within its sector.
Does BAX pay dividends?
BAX has a dividend yield of approximately 0.16%, with an annual dividend of $0.04.
What is the 52-week high and low for BAX?
BAX has recorded a 52-week high of $30.00 and a low of $15.73.
